These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15595571)

  • 1. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose.
    Jug M; Bećirević-Laćan M
    Drug Dev Ind Pharm; 2004; 30(10):1051-60. PubMed ID: 15595571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
    Koester LS; Xavier CR; Mayorga P; Bassani VL
    Eur J Pharm Biopharm; 2003 Jan; 55(1):85-91. PubMed ID: 12551708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes.
    Cao F; Guo J; Ping Q
    Drug Dev Ind Pharm; 2005 Sep; 31(8):747-56. PubMed ID: 16221609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach.
    Patel AR; Vavia PR
    AAPS PharmSciTech; 2008; 9(2):544-50. PubMed ID: 18431648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
    Chowdary KP; Srinivas SV
    AAPS PharmSciTech; 2006 Sep; 7(3):79. PubMed ID: 17025259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
    Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
    Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HPMC concentration on β-cyclodextrin solubilization of norfloxacin.
    Loh GO; Tan YT; Peh KK
    Carbohydr Polym; 2014 Jan; 101():505-10. PubMed ID: 24299805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use.
    Jachowicz R; Czech A
    Pharm Dev Technol; 2008; 13(6):495-504. PubMed ID: 18720246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine/betaCD/HPMC solid dispersions. I. Influence of the spray-drying process and betaCD/HPMC on the drug dissolution profile.
    Koester LS; Mayorga P; Bassani VL
    Drug Dev Ind Pharm; 2003 Feb; 29(2):139-44. PubMed ID: 12648010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets.
    Pose-Vilarnovo B; Rodríguez-Tenreiro C; Rosa dos Santos JF; Vázquez-Doval J; Concheiro A; Alvarez-Lorenzo C; Torres-Labandeira JJ
    J Control Release; 2004 Feb; 94(2-3):351-63. PubMed ID: 14744486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.